在本科医学教育的双学位课程:一个范围审查
Rebecca Landau1, Chelsea Caplan1, Eva Hale1
1Department of Medical Education, University of Miami Miller School of Medicine, Miami, FL, United States.
概括
医学学生越来越多地追求双学位. 本综述综合了这些计划的文献,突出了共同的主题,并确定了医疗教育中的研究差距,以便在未来进行研究.
科学领域:
- 医学教育 医学教育
- 研究生医学研究 研究生医学研究
- 双学位课程 双学位课程
背景情况:
- 与医学教育一起追求双重高级学位是一个日益增长的趋势.
- 综合和双学位课程为医学候选人提供独特的途径.
- 了解这些课程的风景对于学术规划至关重要.
研究的目的:
- 进行对本科医学教育中双学位课程现有文献的范围审查.
- 总结关于双学位课程的最新发现.
- 识别研究缺口,以指导未来在该领域的学术努力.
主要方法:
- 在主要的数据库 (MEDLINE,ERIC,CINAHL,Scopus,Web of Science) 搜索医学双学位的出版物.
- 包括医学博士 (MD) 或骨科医学博士 (DO) 的研究作为一个学位,在美国同时获得,从1964年起出版.
- 对69篇符合条件的文章进行了定性内容分析.
主要成果:
- 确定了69篇讨论各种双学位组合的文章,包括MD/PhD,MD/MPH和MD/MBA课程.
- 在文献中探讨的常见主题包括学生的感知 (35篇文章),课程挑战 (24篇文章),比赛结果 (19篇文章) 和职业选择 (23篇文章).
- 分析的具体双学位类型是MD/PhD,MD/MPH,MD/MBA,MD/MS,MD/JD,MD/DDS,以及DO/PhD.
结论:
- 这一范围审查综合了双学位医疗课程的文献,确定了普遍的主题.
- 关键的研究差距包括毕业生的纵向结果,学生的看法,以及详细评估课程和学术进步挑战.
- 需要进一步的研究,以充分了解医疗教育中的双学位途径的影响和优化.
更多相关视频
13:44Project-Based Learning Guidelines for Health Sciences Students: An Analysis with Data Mining and Qualitative Techniques
Published on: December 9, 2022
3.7K
09:55Bridging the Technology Divide in the COVID-19 Era: Using Virtual Outreach to Expose Middle and High School Students to Imaging Technology
Published on: September 28, 2022
2.1K
相关概念视频
Bioavailability Study Design: Single Versus Multiple Dose Studies
383
Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
383
Bioequivalence of Drugs: Drugs with Multiple Indications
230
The concept of therapeutic equivalence (TE) in drugs with multiple indications is complex. A generic drug may be therapeutically equivalent to a brand-name product for one specific indication, but this doesn't necessarily mean it's equivalent for all other indications. Evidence of TE in one patient group and bioequivalence shown in healthy volunteers can support—but not confirm—TE for other indications. However, definitive proof requires individual clinical studies for each...
230
